A proposed classification of the immunological diseases

PLoS Medicine

Volumn 3, Issue 8, 2006, Pages 1242-1248

  McGonagle, Dennis ^a   McDermott, Michael F ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; COLCHICINE; EFALIZUMAB; ETANERCEPT; NEUTROPHIL CYTOPLASMIC ANTIBODY; RECOMBINANT CYTOKINE; RITUXIMAB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; B LYMPHOCYTE; BEHCET DISEASE; CROHN DISEASE; DENDRITIC CELL; DISEASE CLASSIFICATION; DRUG RESPONSE; DRUG TOLERANCE; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GOUT; HEREDITARY PERIODIC FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; CLASSIFICATION; GENETICS; IMMUNOLOGY; INFLAMMATION;

ARTHRITIS, PSORIATIC; AUTOIMMUNITY; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION;

EID: 33748367018     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030297     Document Type: Article

References (37)

1. Burnet F (1957) A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 20: 67-69.
2. Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345: 340-350.
3. Rioux JD, Abbas AK (2005) Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-589.
4. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14: 426-430.
5. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045.
6. Reimann HA (1949) Periodic disease. Periodic fever, periodic abdominalgia, cyclic neutropenia,intermittent arthralgia, angioneurotic edema,anaphylactoid purpura and periodic paralysis. JAMA 141: 175-182.
7. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, et al. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97: 133-144.
8. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218. E-pub 9 June 2004.
9. Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: Genetics, pathogenesis and treatment. Curr Opin Rheumatol 17: 586-599.
10. Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL (2000) TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 12: 479-486.
11. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL (2003) The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 15: 61-69.
12. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, et al. (2004) Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113: 1296-1306.
13. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
14. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
15. Strober W, Kitani A, Watababe T (2006) Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 6: 9-20.
16. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70: 845-857. E-pub 1 March 2002.
17. Pascual E, Batlle-Gualda E, Martinez A, Rosas J, Vela P (1999) Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 131: 756-759.
18. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 11: 11.
19. McDermott MF (2004) A common pathway in periodic fever syndromes. Trends Immunol 25: 457-460.
20. Wucherpfennig KW (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108: 1097-1104.
21. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, et al. (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 41: 694-700.
22. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D, et al. (2006) A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: Are they the same? Arthritis Rheum 54: 1328-1333.
23. McGonagle D, Stockwin L, Isaacs J, Emery P (2001) An enthesitis based model for the pathogenesis of spondyloarthropathy. Additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 28: 2155-2159.
24. Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, et al. (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42: 551-557.
25. Ferguson PJ, Bing X, Vasef MA, Ochoa LA, Mahgoub A, et al. (2006) A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38: 41-47. E-pub 24 August 2005.
26. Gul A. (2005) Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4: 81-83.
27. Tan AL, Tanner SF, Conaghan PG, Radjenovic A, O'Connor P, et al.(2003) Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum 48: 1214-1222.
28. Rhodes LA, Tan AL, Tanner SF, Radjenovic A, Hensor EM, et al. (2004) Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: Implications for pathogenesis and treatment. Arthritis Rheum 50: 2428-2432.
29. McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352: 1137-1140.
30. Ponticelli C (2003) Altruistic living renal transplantation. J Nephrol 16: S6-S9.
31. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, et al.(1999) An anatomical explanation for good-prognosis rheumatoid arthritis. Lancet 353: 123-124.
32. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50: 607-612.
33. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521. E-pub 7 September 2003.
34. Matzinger P (2002) The danger model: a renewed sense of self. Science 296: 301-305.
35. Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: Why and where it occurs. Nat Med 7: 899-905.
36. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, et al. (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797-801.
37. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, et al. (2005) Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236.